financetom
Business
financetom
/
Business
/
Near 100% capacity utilisation now; H2 seen better YoY: Jindal Stainless
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Near 100% capacity utilisation now; H2 seen better YoY: Jindal Stainless
Oct 19, 2020 2:56 AM

“By September we were running almost at 100 percent of pre-COVID level and H2 we see even better than H2 of the previous year,” said Tarun Khulbe, Director at Jindal Stainless in an interview with CNBC-TV18.

Share Market Live

NSE

Speaking about net debt, he said, “For this year we intend to reduce our debt by Rs 350 crore to Rs 400 crore.”

The government has extended the anti-dumping duty on stainless steel. Khulbe also discussed how this will impact business.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brag House Prices Initial Public Offering
Brag House Prices Initial Public Offering
Mar 6, 2025
04:15 AM EST, 03/06/2025 (MT Newswires) -- Brag House Holdings said late Wednesday it priced its initial public offering of about 1.5 million common shares at $4 each. The underwriters have been granted a 45-day option to purchase up to 221,250 additional shares, the media technology gaming company said. The shares are expected to debut on the Nasdaq Capital Market...
Hercules Capital Prices $250 Million Private Offering of Convertible Notes
Hercules Capital Prices $250 Million Private Offering of Convertible Notes
Mar 6, 2025
04:32 AM EST, 03/06/2025 (MT Newswires) -- Hercules Capital ( HTGC ) said late Wednesday it priced a private placement of $250 million of 4.75% convertible unsecured notes due 2028. The initial purchasers have been granted an option to purchase up to $37.5 million additional amount of notes. The notes will be convertible at an initial price of $21.48 per...
Kestra Medical Technologies Prices $202 Million IPO
Kestra Medical Technologies Prices $202 Million IPO
Mar 6, 2025
04:19 AM EST, 03/06/2025 (MT Newswires) -- Kestra Medical Technologies said Thursday it has priced its upsized initial public offering of about 11.9 shares at $17 per share for gross proceeds of about $202 million. Underwriters will have a 30-day option to purchase up to 1.8 million additional shares, the wearable medical tech company said. The shares are expected to...
Ascentage Pharma's Olverembatinib Granted Breakthrough Therapy Designation in China
Ascentage Pharma's Olverembatinib Granted Breakthrough Therapy Designation in China
Mar 6, 2025
04:33 AM EST, 03/06/2025 (MT Newswires) -- Ascentage Pharma ( AAPG ) said late Wednesday that China's National Medical Products Administration granted the company's olverembatinib drug a breakthrough therapy designation for combination with low-intensity chemotherapy for the first-line treatment of newly diagnosed patients with Philadelphia chromosome-positive acute lymphoblastic leukemia, a type of cancer. The company is commercializing olverembatinib in China...
Copyright 2023-2026 - www.financetom.com All Rights Reserved